Related Experiment Video

Updated: Feb 15, 2026

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
08:56

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

Published on: December 5, 2016

11.4K

N6-methyladenosine links RNA metabolism to cancer progression

Dongjun Dai1, Hanying Wang1, Liyuan Zhu2

  • 1Department of Medical Oncology, Sir Run Run Shaw Hospital, Medical School of Zhejiang University, Hangzhou, China.

Cell Death & Disease
|January 28, 2018
PubMed

Insights

N6-methyladenosine (m6A) is a key RNA modification impacting gene expression and cancer. Targeting m6A regulators shows promise for developing novel cancer therapies by controlling cancer progression.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cancer Research

Background:

  • N6-methyladenosine (m6A) is the most prevalent mRNA modification.
  • m6A influences diverse RNA metabolism processes, including processing, export, translation, and decay.
  • Emerging evidence links m6A to cancer stem cell self-renewal, proliferation, and treatment resistance.

Purpose of the Study:

  • To review the regulatory mechanisms of m6A.
  • To elucidate the multifaceted roles of m6A in human carcinogenesis.
  • To highlight the therapeutic potential of targeting m6A pathways in cancer.

Main Methods:

  • Literature review of antibody-based sequencing technologies.
  • Analysis of m6A "writers", "erasers", and "readers" functions.
  • Synthesis of findings on m6A's role in cancer development and progression.

Main Results:

  • m6A modification is integral to nearly all aspects of mRNA metabolism.
  • m6A dysregulation is implicated in promoting cancer cell proliferation and stemness.
  • Inhibitors targeting m6A factors demonstrate potential in halting cancer progression.

Conclusions:

  • m6A plays a critical role in human carcinogenesis.
  • m6A regulators represent promising therapeutic targets for cancer treatment.
  • Further research into m6A pathways could unlock new anti-cancer strategies.

More Related Videos

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression09:25

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

27.6K
Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry08:45

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry

Published on: April 21, 2022

2.8K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
What is Metabolism?00:52

What is Metabolism?

Overview
132.7K
RNA Structure01:23

RNA Structure

Overview
The basic structure of RNA consists of a five-carbon sugar and one of four nitrogenous bases. Although most RNA is single-stranded, it can form complex secondary and tertiary structures. Such structures play essential roles in the regulation of transcription and translation.
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA): messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three RNA types consist of a...
79.3K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.7K
X-linked Traits01:19

X-linked Traits

In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
59.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K